会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • PARALLEL INDUCIBLE CELL-BASED KINASE SCREEN
    • 平行可诱导基于细胞的激酶筛选
    • WO2004061409A2
    • 2004-07-22
    • PCT/US2002/040757
    • 2002-12-19
    • RIBAPHARM INC.HONG, ZhiRICKETTS, WilliamDIAZ, Paul
    • HONG, ZhiRICKETTS, WilliamDIAZ, Paul
    • G01N
    • C12Q1/485G01N2500/10
    • A parallel inducible cell-based kinase screen (PICKS) includes a plurality of cells that express a kinase gene under the control of an inducer and a reporter gene, wherein the cells are derived from a single cell line, and wherein the reporter gene generates a signal in response to catalytic activity or inhibition of the expressed kinases. Particularly preferred systems include cells expressing kinases from a single kinase signaling pathway, kinases from a kinase family, and/or kinases from various different kinase signaling pathways. Consequently, contemplated systems provide a platform for screening for novel kinase inhibitors, inhibition specificity of particular kinase inhibitors, and for analysis of inter-pathway and/or intra-pathway inhibition of a kinase inhibitor.
    • 平行可诱导的基于细胞的激酶筛选(PICKS)包括在诱导物和报道基因的控制下表达激酶基因的多个细胞,其中所述细胞衍生自单个细胞系,并且其中所述报告基因产生 响应于催化活性或抑制表达的激酶的信号。 特别优选的系统包括表达来自单一激酶信号通路的激酶的细胞,来自激酶家族的激酶和/或来自各种不同激酶信号通路的激酶。 因此,预期的系统提供筛选新型激酶抑制剂的平台,特异性激酶抑制剂的抑制特异性,以及激酶抑制剂的通路间途径和/或通路内抑制的分析。
    • 4. 发明申请
    • PARALLEL INDUCIBLE CELL-BASED KINASE SCREEN
    • 平行诱导的基于细胞的激酶屏
    • WO2004061409A3
    • 2004-10-14
    • PCT/US0240757
    • 2002-12-19
    • RIBAPHARM INCHONG ZHIRICKETTS WILLIAMDIAZ PAUL
    • HONG ZHIRICKETTS WILLIAMDIAZ PAUL
    • C12Q1/02C12Q1/48G01N20060101
    • C12Q1/485G01N2500/10
    • A parallel inducible cell-based kinase screen (PICKS) includes a plurality of cells that express a kinase gene under the control of an inducer and a reporter gene, wherein the cells are derived from a single cell line, and wherein the reporter gene generates a signal in response to catalytic activity or inhibition of the expressed kinases. Particularly preferred systems include cells expressing kinases from a single kinase signaling pathway, kinases from a kinase family, and/or kinases from various different kinase signaling pathways. Consequently, contemplated systems provide a platform for screening for novel kinase inhibitors, inhibition specificity of particular kinase inhibitors, and for analysis of inter-pathway and/or intra-pathway inhibition of a kinase inhibitor.
    • 平行诱导型基于细胞的激酶筛选(PICKS)包括多个在诱导剂和报道基因控制下表达激酶基因的细胞,其中所述细胞来源于单细胞系,并且其中所述报道基因产生 响应催化活性或抑制表达的激酶而发出信号。 特别优选的系统包括表达来自单一激酶信号传导途径的激酶,来自激酶家族的激酶和/或来自各种不同激酶信号传导途径的激酶的细胞。 因此,所设想的系统提供了用于筛选新型激酶抑制剂,抑制特定激酶抑制剂的特异性以及用于分析激酶抑制剂的途径间和/或途径内抑制的平台。